Abstract:Objectives: Due to rheumatic heart disease, young people are more likely to develop valvular heart disease in developing countries. In countries like Pakistan, surgeons implant more bioprosthetic mitral valves (MVs) in younger patients. However, bioprosthetic valves degenerate rapidly in younger people, leading to bioprosthetic MV dysfunction (BMVD). This study aims to evaluate the clinical characteristics and long-term outcomes of patients with bioprosthetic MV replacement (MVR) at a tertiary care hospital in a South Asian country. Material and methods: This is a retrospective observational study, conducted at a tertiary care hospital. We included a total of 502 patients who underwent bioprosthetic MVR from the year 2006 to 2020. Clinical and surgical characteristics along with transthoracic echocardiographic findings (pre-surgery and recent most follow-up studies) were noted. Follow-up data were also collected. Results: Out of 502 patients, 322 (64%) were female, mean age at the time of surgery was 49.42 ± 14.56 years. Mitral regurgitation was more common, found in 279 (55.6%) patients followed by mitral stenosis in 188 (37.5%) patients. MVR was done as an elective procedure due to the New York Heart Association (NYHA) II to IV symptoms at the time of surgery in 446 (88.8%) patients. In the mean follow-up of 6.59 ± 2.99 years, BMVD was observed in 183 (36.5%) patients. However, re-do MV surgery was done in only 49 (9.8%) patients. Patients were divided into two groups based on normal functioning bioprosthetic MV and BMVD. Comparing the two groups, individuals with normal functioning bioprosthetic MV had a mean age of 51.6 ± 14.27 years, while those with BMVD had a mean age of 45.639 ± 14.33 years at the time of index surgery (P = 0.000). There were more long-term complications including heart failure (n = 16, 8.74%), atrial fibrillation (n = 11, 6.01%), and death (n = 6, 3.28%) in the BMVD group which were statistically significant. Conclusion: This study is distinct because it demonstrates the outcomes of bioprosthetic valve replacement in a relatively younger South Asian population. Due to rapid degeneration of bioprosthetic valve in younger patients, significant number of patients developed BMVD along with poor long-term clinical outcomes, even at a short follow-up period of <10 years. These findings are similar to international data and signify that mechanical MVR may be a more reasonable alternative in younger patients.

CLINICAL PROFILE OF PATIENTS UNDERGOING PERCUTANEOUS BALLOON MITRAL VALVOTOMY AND BODY SURFACE AREA BASED MITRAL VALVE AREA ASSESSMENT

Clinical Effect of Percutaneous Balloon Mitral Valvuloplasty in Treatment of Rheumatic Mitral Stenosis

Effects of Percutaneous Balloon Mitral Valvuloplasty on Plasma B-type Natriuretic Peptide in Rheumatic Mitral Stenosis with and Without Atrial Fibrillation.

Changes of Plasma B-type Natriuretic Peptide after Percutanouse Balloon Mitral Valvuloplasty

Effects of Percutaneous Balloon Mitrai Valvuloplasty on Plasma B-type Natriuretic Peptide in Rheumatic Mitral Stenosis Patients

Clinical application of percutaneous balloon mitral valvuloplasty in patients with rheumatic mitral stenosis and left atrial thrombi

A study of Clinical Profile and in Hospital Outcomes of patients undergoing Percutaneous Transvenous Mitral Commissurotomy at a Tertiary Care Center of Nepal

Relation of Body Mass Index to Long-Term Survival and Cardiac Remodeling for Patients Undergoing Mitral Valve Replacement Surgery

Incidence and predictors of adverse outcomes in patients with rheumatic mitral stenosis following percutaneous balloon mitral valvuloplasty: a study from a tertiary center in Thailand

Clinical characteristics and long-term outcome of patients with bioprosthetic mitral valve- Experience from a South Asian country

Body Mass Index Impact On Minimally Invasive Mitral Valve Surgery: Report From A Multicenter Registry

Evaluation on Results of Repeat Percutaneous Balloon Mitral Valvuloplasty for Mitral Restenosis Following Prior Balloon Valvuloplasty

Assessment of function on left atrial and biventricular in patients with rheumatic mitral stenosis before and after percutaneous mitral balloon valvuloplasty by real-time three-dimensional echocardiography

Systemic Immune Inflammation-Index and CANLPH Score in Patients with Mitral Stenosis Undergoing Balloon Valvuloplasty

Impact of commissural calcification on clinical outcome of percutaneous balloon mitral valvuloplasty; a retrospective cohort study of 876 patients

Short Term and Long-Term Results of Percutaneous Balloon Mitral Valvuloplasty in Patients with Mitral Stenosis and Atrial Fibrillation

Revisiting percutaneous balloon mitral valvotomy technique and safety in various population: an evidence-based case report and literature review

Effect of patient prosthesis mismatch on clinical outcomes following surgical aortic valve replacement

Childbearing Performances and Outcomes of Female Patients with Rheumatic Mitral Valve Diseases after Different Mitral Interventions

Impact of Net Atrioventricular Compliance on Mitral Valve Area Assessment-A Perspective Considering Three-Dimensional Mitral Valve Area by Transesophageal Echocardiography

The Application of Echocardiography to Guide Interatrial Septal Puncture and Evaluate the Clinical Effect in Percutaneous Balloon Mitral Valvuloplasty